Case Discussions in Parenteral Nutrition: Improving Outcomes for Patients in 2021 and Beyond (CE/CME Webcast)
Activity Description and Purpose
New research into the role of various intravenous lipid emulsion (ILE) formulations in managing nutrition in the critically ill and those at risk of elevated systemic inflammation has evolved drastically in the last few years. New evidence and guidelines suggest that fish oil–containing ILEs reduce systemic inflammation and should be used preferentially in hospitalized patients who are critically ill, including those with COVID-19. Fish oil–containing ILEs have also been shown to reduce the risk of parenteral nutrition (PN)-associated liver disease among patients on long-term PN. In this webcast, which captures the proceedings of a live virtual CE/CME symposium held during the ASPEN21 Virtual Conference, experts apply new guidelines and evidence to a variety of patient scenarios. The desired results of this educational activity are to increase knowledge of the evidence and best practices in PN among clinicians and to enable confidence selecting and dosing ILEs in a variety of adult patient scenarios.
This activity is intended for US dietitians, pharmacists, nurses, and physicians engaged in the care of adult patients requiring parenteral nutrition.
After completing this activity, the participant should be better able to:
- Discuss recent recommendations for the selection of ILEs in hospitalized and home patients and the rationale behind them
- Compare the effects of various ILEs on liver function parameters and risk of developing parenteral nutrition–associated liver disease
- Translate recent recommendations on the use of ILEs to various clinical scenarios
|Phil Ayers, PharmD, BCNSP, FASHP (Chair)|
Clinical Associate Professor
Chief of Clinical Pharmacy Services
School of Pharmacy
University of Mississippi
|David C. Evans, MD, FACS, PNS|
Ohio Health System Nutrition Support Team
|Carol S. Ireton-Jones, PhD, RD, CNSC, FASPEN|
Department of Nutritional Sciences
College of Human Sciences
Texas Tech University
Nutrition Therapy Specialist
Good Nutrition for Good Living
Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.
Phil Ayers, PharmD
Consulting fees (eg, advisory boards) from American Regent, Inc
Fees for non-CME/CE services received directly from a commercial interest or their agents (eg, speakers’ bureaus) from Fresenius Kabi USA
David C. Evans, MD
Consulting fees (eg, advisory boards) from Abbott; Coram LLC; and Fresenius Kabi USA
Fees for non-CME/CE services received directly from a commercial interest or their agents (eg, speakers’ bureaus) from Abbott; Alcresta Therapeutics, Inc; and Fresenius Kabi USA
Carol S. Ireton-Jones, PhD, RD
Salary from Nutrishare, Inc
Consulting fees (eg, advisory boards) from Fresenius Kabi USA and Nestlé
Planners, Managers, and Reviewers
The PIM planners, managers, and reviewers have nothing to disclose. The MedEdicus planners and managers have nothing to disclose.
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and MedEdicus LLC. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Dietitian Continuing Education
Postgraduate Institute for Medicine (CDR Provider #3631) is a Continuing Professional Education (CPE) Accredited Provider with the Commission on Dietetic Registration (CDR). CDR Credentialed Practitioners will receive 1.5 Continuing Professional Education units (CPEUs) for completion of this activity. This is a Level II activity.
Continuing Pharmacy Education
Postgraduate Institute for Medicine designates this continuing education activity for 1.5 contact hours (0.15 CEUs) of the Accreditation Council for Pharmacy Education. (Universal Activity Number - JA4008162-9999-21-2851-H01-P)
Type of Activity: Knowledge
Continuing Nursing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.5 contact hours. Designated for 0.75 contact hour of pharmacotherapy credit for Advanced Practice Registered Nurses.
Physician Continuing Medical Education
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Method of Participation and Request for Credit
There are no fees for participating and receiving CME/CE credit for this activity. During the period June 21, 2021, through June 30, 2022, participants must read the learning objectives and faculty disclosures and study the educational activity.
If you wish to receive acknowledgment for completing this activity, please complete the post-test and evaluation. Upon registering and successfully completing the post-test with a score of 75% or better and the activity evaluation, your certificate will be made available immediately.
Disclosure of Commercial Support
This activity is supported by an independent educational grant from Fresenius Kabi USA.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
Policy on Privacy and Confidentiality
This continuing medical education activity is jointly provided by Postgraduate Institute for Medicine and MedEdicus LLC.
This CME/CE activity is copyrighted to MedEdicus LLC ©2021. All rights reserved. 247
- 1.50 ACPE
- 1.50 AMA PRA Category 1 Credit™
- 1.50 ANCC
- 1.50 CDR
- 1.50 Participation